Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Dec 2, 2011

30071_dirs_2011-12-02_a345dc5c-d510-4e65-99c4-f0b1b3f4ad02.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-11-30

Reporting Person: Darkin Donald (Pres. SDB SBU)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-30 ResMed Common Stock M 2000 $21.025 Acquired 54143 Direct
2011-11-30 ResMed Common Stock S 2000 $26.225 Disposed 52143 Direct
2011-11-30 ResMed Common Stock M 30000 $15.520 Acquired 82143 Direct
2011-11-30 ResMed Common Stock S 30000 $26.101 Disposed 52143 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-11-30 ResMed Common Stock Options $21.025 M 2000 Disposed 2014-11-07 ResMed CommonStock (2000) Direct
2011-11-30 ResMed Common Stock $15.520 M 30000 Disposed 2015-10-01 ResMed Common Stock (30000) Direct

Footnotes

F1: Represents date options first became exercisable.

F2: This transaction was executed in multple trades at prices ranging from $25.99 to $26.23. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.